Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.66 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.56 |
| ▸ | NRP1 | O14786 | 3/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 7/20 | 0.50 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.50 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1247726 | 0.97 | GRB2 (0.61) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL29362706 | 0.90 | GRB2 (0.67) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL12237919 | 0.87 | GRB2 (0.50) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL12899266 | 0.87 | GRB2 (0.50) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL14227389 | 0.87 | GRB2 (0.50) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL13084631 | 0.87 | GRB2 (0.50) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL12261069 | 0.87 | GRB2 (0.50) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL29364463 | 0.86 | APLNR (0.55) | GRB2F2CAPN1NRP1NTSR1 | |
| SCHEMBL29445609 | 0.85 | F2 (0.57) | GRB2F2NRP1NTSR1NTSR2 | |
| SCHEMBL1247795 | 0.83 | OPRM1 (0.48) | GRB2F2NRP1NTSR1NTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12290569-B2 | Methods and compositions using peptides and proteins with c-terminal elements | Sanford Burnham Prebys Medical Discovery Institute (US) | 2025-05-06 | — | — | US | claimed |
| CN-114062564-B | Detection method of taffeta and variants thereof | 北京第一生物化学药业有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114062564-A | Detection method of taffeta and variants thereof | 北京第一生物化学药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20260048133-A1 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2026-02-19 | — | — | US | disclosed |
| US-12290569-B2 | Methods and compositions using peptides and proteins with c-terminal elements | Sanford Burnham Prebys Medical Discovery Institute (US) | 2025-05-06 | — | — | US | disclosed |
| EP-2953978-B1 | PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF | TPCERA LTD (IL) | 2024-10-23 | — | — | EP | disclosed |
| US-11795197-B2 | Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230173097-A1 | METHODS AND COMPOSITIONS RELATED TO PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 2023-06-08 | — | — | US | disclosed |
| EP-2250278-B1 | METHODS AND COMPOSITIONS RELATED TO PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | BURNHAM INSTITUTE FOR MEDICAL RES (US) | 2023-04-05 | — | — | EP | disclosed |
| US-11472844-B2 | Peptidomimetics, method of synthesis and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-10-18 | — | — | US | disclosed |
| US-20220175941-A1 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 2022-06-09 | — | — | US | disclosed |
| EP-3724215-B1 | PEPTIDOMIMETICS, METHOD OF SYNTHESIS AND USES THEREOF | PASTEUR INSTITUT (FR) | 2022-04-13 | — | — | EP | disclosed |
| CN-114062564-B | Detection method of taffeta and variants thereof | 北京第一生物化学药业有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-11260133-B2 | Methods and compositions related to peptides and proteins with C-terminal elements | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2022-03-01 | — | — | US | disclosed |
| CN-114062564-A | Detection method of taffeta and variants thereof | 北京第一生物化学药业有限公司 | 2022-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11260133-B2 | Methods and compositions related to peptides and proteins with C-terminal elements | CD2BP2, CLTC, CLTA | GRB2 264/4885F2 3960/4885CAPN1 444/4885 |
| US-20260048133-A1 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | CMKLR2, CRKL, CMKLR1 | GRB2 702/4885F2 4068/4885CAPN1 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.